Circulating human factor IX produced in keratin promoter transgenic mice: A feasibility study for gene therapy of haemophilia B

Human Molecular Genetics

Volumn 4, Issue 6, 1995, Pages 993-999

  Alexander, M Y ^a   Bidichandani, S I ^a   Cousins, F M ^a   Robinson, C J M ^a   Duffie, E ^a   Akhurst, R J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; COMPLEMENTARY DNA; CYTOKERATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION; GENE THERAPY; HEMOPHILIA B; KERATINOCYTE; MALE; MEMBRANE TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMIC CIRCULATION; TRANSGENIC MOUSE;

ANIMAL; BASE SEQUENCE; DNA; EPIDERMIS; FACTOR IX; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION; GENE THERAPY; HEMOPHILIA B; HUMAN; KERATIN; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0029001591     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/4.6.993     Document Type: Article

References (36)

1. Hedner, U. and Davie, E.W. (1989) Introduction to haemeostasis and the vitamin K-dependent coagulation factors. In Scriver (ed.). The Metabolic Basis of Inherited Diseases. McGraw-Hill, New York, pp. 2107-2134.
2. Hay, C.R.M., Preston, F.E., Trigger, D.R., Underwood, J.C.F. (1985) Progressive liver disease in haemophilia A: An understated problem. Lancet, 1, 1495-1498.
3. Spero, J. A. (1991) Complications in the treatment of haemostatic disorders. In Ratnoff, O. D. and Forbes, C.D. (eds), Disorders of Hemostasis. W.B. Saunders, Philadelphia, pp. 555-575.
4. Kay, M.A., Rothenberg, S., Landen, C.N., Bellinger, D.A., Leland, F., Torman, C., Finegold, M., Thompson, A.R., Read, M.S., Brinkhous, K.M., and Woo, S.L.C. (1993) In vivo gene therapy of hemophilia B sustained partial correction in factor IX-deficient dogs. Science, 262, 117-119.
5. Palmer, T.D., Thompson, A.R., and Miller, A.D. (1989) Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood, 73, 438-445.
6. Scharfmann, R., Axelrod, J.H., and Verma, I.M. (1991) Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl Acad. Sci. USA, 88, 4626-4630.
7. Yao, S., Wilson, J.M., Nabel, E.G., Kurachi, S., Hachiya, H.L., and Kurachi, K. (1991) Expression of human factor IX in rat capillary endothelial cells: Towards somatic gene therapy for hemophilia B. Proc. Natl Acad. Sci. USA, 88, 8101-8105.
8. Dai, Y., Roman, M., Naviaux, R.K., and Verma, I.M. (1992) Gene therapy via primary myoblasts: long term expression of factor IX protein following transplantation in vivo. Proc. Natl Acad. Sci. USA, 89, 10892-10895.
9. Yao, S. and Kurachi, K. (1992) Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl Acad. Sci. USA, 89, 3357-3361.
10. Gerrard, A.J., Hudson, D.L., Brownlee, G.G., and Watt, F.M. (1993) Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genet., 3, 180-183.
11. Vogel, J. (1993) Keratinocyte gene therapy. Arch. Dermatol., 129, 1478-1483.
12. Gallico, G.G., O’Conner, N.E., Compton, C.C., Kehinde, O., and Green, H. (1984) Permanent coverage of large bum wounds with autologous cultured human epithelium. N. Engl. J. Med., 311, 448-451.
13. Fenjves, E.S., Gordon, D.A., Pershing, L.K., Williams, D.L., and Taichman, L.R. (1989) Systematic distribution of apoliprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc. Natl Acad. Sci. USA, 86, 8803-8807.
14. Armentano, D., Thompson, A.R., Darlington, G., and Woo, S.L.C. (1990) Expression of human factor IX in rabbit hepatocytes by retrovirus mediated gene transfer: potential for gene therapy of hemophilia B. Proc. Natl Acad. Sci. USA, 87, 6141-6145.
15. Morgan, I. F., Barrandon, Y., Green, H„ and Mulligan, R.C. (1987) Expression of an exogenous growth hormone gene by transplantable.human epidermal cells. Science, 237, 1476-1479.
16. Flowers, M.E.D., Stockschlaeder, M.A.R., Schuening, F.G., Niederwieser, D., Hackman, R., (1990) Long term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc. Natl Acad, Sci. USA, 87, 2349-2353.
17. Jorcano, J.L., Franz, J.K., and Franke, W.W. (1984) Amino acid diversity between bovine epidermal cytokeratin polypeptides of the basic (type II) subfamily as determined from cDNA clones. J. Mol. Biol., 179, 257-281.
18. Choo, K.H., Raphael, K., McAdam, W., and Peterson, M.G. (1987) Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA coding region. Nucleic Acids Res., 15, 871-884.
19. Blessing, M., Zentgraf, H., and Jorcano, J.L. (1987) Differentially expressed bovine cytokeratin genes. Analysis of gene linkage and evolutionary conservation of 5' upstream sequences. EMBO J., 6, 567-575.
20. Anson, D.S., Austen, D.E.G., and Brownlee, G.G. (1985) Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells. Nature, 315, 683-685.
21. Mulligan, R., Howard, B., and Berg, P. (1979) Synthesis of rabbit (3-globin in cultured monkey cells following infection with a SV40 (3-globin recombinant genome. Nature, 277, 108-114.
22. Bailleul, B., Surani, M.A., White, S., Barton, S.C., Brown, K., Blessing, M., Jorcano, J., and Balmain, A. (1990) Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell, 62, 697-708.
23. Allen, N.D., Barton, S.C., Surani, M.A.H., and Reik, W. (1987) Production of transgenic mice. In Monk, M. (ed.), Mammalian Development: A practical approach. IRL Press, Oxford, pp. 217-232.
24. Smith, K.J. and Ono, K. (1984) Monoclonal antibodies to factor IX: characterisation and use in immunoassays for factor IX. Thromb. Res., 33, 211-224.
25. Smith, K.J. (1988) Immunoaffinity purification of factor IX from commercial concentrates and infusion studies on animals. Blood, 72, 1269-1277.
26. Gerrard, A.J., Austen, D.E.G., and Brownlee, G.G. (1992) Subcutaneous injection of factor IX for the treatment of haemophilia B. Br. J. Haematol., 81, 610-613.
27. Teumer, J., Lindahl, A., and Green, H. (1990) Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes. FASEB J., 4, 3245-3250.
28. Biggs, R. and Denson, K.W.E. (1963) The fate of prothrombin and factors VIII, IX, and X transfused to patients deficient in these factors. Br. J. Haematol., 9, 532-547.
29. Greenhalgh, D.A., Rothnagel, J.A., Quintanilia, M.I., Orengo, C.C., Gagne, T.A., Bundman, D.S., Longley, M.A., and Roop, D.R. (1993) Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinogen., 7, 99-110.
30. Sellheyer, K., Bickenbach, J.R., Rothnagel, J.A., Bundman, D., Longley, M.A., Krieg, T., Roche, N.S., Roberts, A.B., and Roop, D.R. (1993) Inhibition of skin development by overexpression of transforming growth factor pi in the epidermis of transgenic mice. Proc. Natl Acad. Sci. USA., 90, 5237-5241.
31. Axelrod, J.H., Read, M.S., Brinkhouse, K.M., and Verma, I.M. (1990) Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophiliac dogs. Proc. Natl Acad. Sci. USA, 87, 5173-5177.
32. Marsh, J.L., Erfle, M., and Wykes, E.J. (1984) The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene, 32, 481-485.
33. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York.
34. Tso, J.Y., Sun, X.H., and Kao, T.H. (1982) Isolation and characterisation of rat and human GAPDH cDNAs:Genomic complexity and molecular evolution of the gene. Nucleic Acids Res., 13, 2485-2502.
35. Akhurst, R.J. (1993) Localisation of growth factor mRNA in tissue sections by in situ hybridisation. In McKay, I. and Leigh, I. (eds.), Growth Factors. A practical approachARL Press, Oxford, pp. 109-132.
36. Cui, W., Fowlis, D.J., Cousins, F.M., Duffre, E., Bryson, S., Balmain, A. and Akhurst, R.J. (1995) Concerted action of TGFB and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes and Development, in press.